Heterospecific modification as a means to clone restriction genes
AssigneeNew England Biolabs, Inc.
InventorsGeoffrey G. Wilson, Marta M. Meda
Life of this patent
Estimating the term…
Loading patent…
AssigneeNew England Biolabs, Inc.
InventorsGeoffrey G. Wilson, Marta M. Meda
Estimating the term…
The present invention provides a novel approach to the production of restriction enzymes. More specifically, there is provided a novel method for cloning these enzymes, which comprises preparing DNA libraries from the DNA of an organism that synthesizes the restriction enzyme of interest, creating a suitable host containing a heterospecific methyltransferase gene able to protectively modify DNA from digestion by the restriction enzyme of interest, introducing the DNA libraries into the protectively modified host, and screening recombinant organisms to identify those carrying the desired restriction enzyme gene. The application of this method to the FspI and HaeIII restriction genes of Fischerella species and Haemophilus aegyptius, respectively, is described in detail, together with the resulting clones that form the basis of a new and useful process for purifying the FspI and HaeIII restriction enzymes.
A method of cloning a restriction endonuclease gene comprising the following steps:
A DNA fragment consisting essentially of a nucleotide sequence which encodes the HaeIII restriction endonuclease produced by Haemophilus aegyptius ATCC No. 11116.
A method for producing a restriction endonuclease comprising the following steps:
Dependencies are inferred from the claim text.